| Microbiome impact on metabolism and function of sex, thyroid, growth and parathyroid hormones. M Kunc, A Gabrych, JM Witkowski Acta Biochimica Polonica 63 (2), 189-201, 2016 | 84 | 2016 |
| Estrogen receptor-negative progesterone receptor-positive breast cancer–“Nobody's land “or just an artifact? M Kunc, W Biernat, E Senkus-Konefka Cancer treatment reviews 67, 78-87, 2018 | 64 | 2018 |
| Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment P Czapiewski, M Kunc, J Haybaeck Oncotarget 7 (32), 52584, 2016 | 54 | 2016 |
| Paraneoplastic syndromes in olfactory neuroblastoma M Kunc, A Gabrych, P Czapiewski, K Sworczak Contemporary Oncology/Współczesna Onkologia 19 (1), 36-42, 2015 | 41 | 2015 |
| Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature P Czapiewski, M Kunc, A Gorczyński, J Haybaeck, K Okoń, J Reszec, ... Human pathology 79, 144-150, 2018 | 29 | 2018 |
| Clinicopathological comparison and therapeutic approach to Castleman disease—a case-based review M Wojtyś, A Piekarska, M Kunc, K Ptaszyński, W Biernat, JM Zaucha, ... Journal of thoracic disease 11 (11), 4859, 2019 | 20 | 2019 |
| MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma M Bieńkowski, M Kunc, M Iliszko, A Kuźniacka, M Studniarek, W Biernat Virchows Archiv 477 (3), 393-400, 2020 | 18 | 2020 |
| Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma MA Krawczyk, M Styczewska, EM Sokolewicz, M Kunc, A Gabrych, ... Biomarkers 24 (6), 538-548, 2019 | 18 | 2019 |
| Combined assessment of immune checkpoint regulator VISTA on tumor-associated immune cells and platelet-to-Lymphocyte ratio identifies advanced germ cell tumors with higher risk … R Pęksa, M Kunc, M Popęda, M Piątek, M Bieńkowski, J Żok, ... Cancers 13 (8), 1750, 2021 | 13 | 2021 |
| High PD-L1 expression on tumor cells indicates worse overall survival in advanced oral squamous cell carcinomas of the tongue and the floor of the mouth but not in other oral … ŁJ Adamski, A Starzyńska, P Adamska, M Kunc, M Sakowicz-Burkiewicz, ... Biomedicines 9 (9), 1132, 2021 | 12 | 2021 |
| The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma A Gabrych, R Pęksa, M Kunc, M Krawczyk, E Izycka-Swieszewska, ... Pathology-Research and Practice 215 (12), 152700, 2019 | 12 | 2019 |
| Diagnostic test accuracy meta‐analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions M Kunc, N Żemierowska, F Skowronek, W Biernat Histopathology 83 (1), 3-14, 2023 | 11 | 2023 |
| Lost but not least—novel insights into progesterone receptor loss in estrogen receptor-positive breast cancer M Kunc, M Popęda, W Biernat, E Senkus Cancers 13 (19), 4755, 2021 | 11 | 2021 |
| Analysis of clinicopathological factors influencing survival in patients with renal cell carcinoma and venous tumor thrombus Ł Zapała, S Sharma, M Kunc, P Zapała, J Kłącz, P Korczyński, M Lipowski, ... Journal of Clinical Medicine 10 (17), 3852, 2021 | 10 | 2021 |
| microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study M Kunc, M Popęda, A Szałkowska, M Niemira, M Bieńkowski, R Pęksa, ... Diagnostics 10 (9), 617, 2020 | 8 | 2020 |
| Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor MA Krawczyk, G Karpinsky, E Izycka-Swieszewska, A Gabrych, M Kunc, ... Cancer Biomarkers 24 (3), 351-361, 2019 | 8 | 2019 |
| Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma P Czapiewski, A Gorczyński, J Haybaeck, K Okoń, J Reszeć, ... Polish Journal of Pathology 67 (2), 130-135, 2016 | 8 | 2016 |
| Low lymphocyte-to-monocyte ratio is the potential indicator of worse overall survival in patients with renal cell carcinoma and venous tumor thrombus Ł Zapała, M Kunc, S Sharma, W Biernat, P Radziszewski Diagnostics 11 (11), 2159, 2021 | 7 | 2021 |
| An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite P Mierzejewska, M Kunc, MA Zabielska-Kaczorowska, B Kutryb-Zajac, ... Experimental & Molecular Medicine 53 (9), 1402-1412, 2021 | 7 | 2021 |
| High expression of solute carrier family 2 member 1 (SLC2A1) in cancer cells is an independent unfavorable prognostic factor in pediatric malignant peripheral nerve sheath tumor MA Krawczyk, M Kunc, M Styczewska, A Gabrych, G Karpinsky, ... Diagnostics 11 (4), 598, 2021 | 7 | 2021 |
